Tingwei Su

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Gut microbiota signatures in primary aldosteronism and functional identification of an aldosterone-degrading gut bacterium.

Gut microbiota signatures in primary aldosteronism and functional identification of an aldosterone-degrading gut bacterium.

Journal: Gut microbes

Published: April 11, 2026

Annexin A1 as a diagnostic biomarker for cyclic Cushing disease.

Annexin A1 as a diagnostic biomarker for cyclic Cushing disease.

Journal: iScience

Published: April 09, 2026

Molecular Subtyping of Adrenocortical Carcinoma Reveals Distinct Subtypes with Prognostic and Therapeutic Implications.

Molecular Subtyping of Adrenocortical Carcinoma Reveals Distinct Subtypes with Prognostic and Therapeutic Implications.

Journal: Endocrine-related cancer

Published: September 01, 2025

The neurosurgical outcome of pediatric Cushing's disease in a single center from China: a 20-year experience.

The neurosurgical outcome of pediatric Cushing's disease in a single center from China: a 20-year experience.

Journal: Frontiers in endocrinology

Published: July 10, 2025

Recurrent CACNA1HE282K is a gain-of-function mutation associated with primary hyperaldosteronism.

Recurrent CACNA1HE282K is a gain-of-function mutation associated with primary hyperaldosteronism.

Journal: European journal of endocrinology

Published: July 04, 2025

The USP8 Mutational Status in Combination With Postsurgical Cortisol Levels for Predicting Recurrence of Cushing Disease.

The USP8 Mutational Status in Combination With Postsurgical Cortisol Levels for Predicting Recurrence of Cushing Disease.

Journal: The Journal of clinical endocrinology and metabolism

Published: March 13, 2025

Suppressed Renin Status Is a Risk Factor for Cardiocerebrovascular Events in Bilateral Primary Aldosteronism Treated With Mineralocorticoid Receptor Antagonists.

Suppressed Renin Status Is a Risk Factor for Cardiocerebrovascular Events in Bilateral Primary Aldosteronism Treated With Mineralocorticoid Receptor Antagonists.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: July 10, 2024

Assessment of Optical Attenuation and Skin Thickness in Type 2 Diabetes Mellitus Patients Using Optical Coherence Tomography.

Assessment of Optical Attenuation and Skin Thickness in Type 2 Diabetes Mellitus Patients Using Optical Coherence Tomography.

Journal: Journal of biophotonics

Published: June 16, 2024

ERRATUM: Mutational landscape of non-functional adrenocortical adenomas.

ERRATUM: Mutational landscape of non-functional adrenocortical adenomas.

Journal: Endocrine-related cancer

Published: January 29, 2024

The influence of cortisol co-secretion on clinical characteristics and postoperative outcomes in unilateral primary aldosteronism.

The influence of cortisol co-secretion on clinical characteristics and postoperative outcomes in unilateral primary aldosteronism.

Journal: Frontiers in endocrinology

Published: January 12, 2024

Pharmacogenomic analysis in adrenocortical carcinoma reveals genetic features associated with mitotane sensitivity and potential therapeutics.

Pharmacogenomic analysis in adrenocortical carcinoma reveals genetic features associated with mitotane sensitivity and potential therapeutics.

Journal: Frontiers in endocrinology

Published: January 04, 2024

Efficacy and safety of adjuvant radiation therapy in localized adrenocortical carcinoma.

Efficacy and safety of adjuvant radiation therapy in localized adrenocortical carcinoma.

Journal: Frontiers in endocrinology

Published: October 06, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026